← Back to Search

Opioid Partial Agonist

Telehealth Intervention for Opioid Overdose (BBB Trial)

N/A
Recruiting
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1,2,4,8,and 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if telemedicine intervention delivered through public libraries can help reduce opioid overdoses among unstably housed individuals.

Who is the study for?
This trial is for individuals seeking treatment for opioid use disorder (OUD), regardless of their OUD and treatment history. It's open to library patrons who are not currently on buprenorphine with an active medical prescriber, or those who need a new provider. Accommodations will be made for participants with disabilities.
What is being tested?
The 'Bupe by the Book' study tests if using telehealth in public libraries can improve access to buprenorphine treatment for unstably housed individuals. Participants will be randomly assigned to either weekly telehealth sessions at the library or standard in-person clinic visits over a period of 12 weeks.
What are the potential side effects?
While specific side effects are not listed, buprenorphine may commonly cause symptoms like nausea, drowsiness, constipation, headache, or sweating. Side effects vary from person to person.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1,2,4,8,and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1,2,4,8,and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
buprenorphine adherence
buprenorphine uptake
Secondary study objectives
Opioid use/overdose and other substance use
adherence to appointments
telebupe feasibility

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Treatment as UsualExperimental Treatment2 Interventions
Treatment as usual (in-person at clinic)
Group II: TelehealthExperimental Treatment1 Intervention
Intervention arm
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Control group
2020
N/A
~1870

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,180 Previous Clinical Trials
1,574,996 Total Patients Enrolled
San Diego State UniversityOTHER
169 Previous Clinical Trials
114,814 Total Patients Enrolled

Media Library

Buprenorphine (Opioid Partial Agonist) Clinical Trial Eligibility Overview. Trial Name: NCT05872386 — N/A
Control Group Research Study Groups: Telehealth, Treatment as Usual
Control Group Clinical Trial 2023: Buprenorphine Highlights & Side Effects. Trial Name: NCT05872386 — N/A
Buprenorphine (Opioid Partial Agonist) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05872386 — N/A
~26 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top